# COMAR Title 10 — Maryland Department of Health

## Subtitle 52 — Preventive Medicine

### Chapter 15 — Screening for Critical Congenital Heart Disease (CCHD) in Newborns

#### Regulation .08 Records.

*COMAR 10.52.15.08*

A. The screening of newborn infants pursuant to this chapter is a population-based public health surveillance program as defined under the Health Insurance Portability and Accountability Act of 1996.

B. On request, a birthing facility or health care provider shall make available to the Newborn Screening Follow-Up Unit:

  (1) Medical records;

  (2) Records of laboratory tests; and

  (3) Any other medical information the Newborn Screening Follow-Up Unit considers necessary to:

    (a) Determine final outcomes of abnormal screening results; and

    (b) Evaluate CCHD Screening activities in the State, including:

      (i) Performance of follow-up evaluations and diagnostic tests;

      (ii) Initiation of treatment when necessary; and

      (iii) Surveillance of the accuracy and efficacy of the screening.

C. Information that the Department receives under this chapter is confidential and may only be used or disclosed:

  (1) To provide services to the newborn infant and the infant's family;

  (2) To study the relationships of the various factors determining the frequency and distribution of CCHD;

  (3) For State or federally mandated statistical reports; and

  (4) To ensure that the information received by the Department is accurate and reliable.